| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |